A BILL 
To require a longitudinal study on the impact of COVID– 
19. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Ensuring Under-
4
standing of COVID–19 to Protect Public Health Act’’. 
5
SEC. 2. STUDY ON THE IMPACT OF COVID–19. 
6
Part A of title IV of the Public Health Service Act 
7
(42 U.S.C. 281 et seq.) is amended by adding at the end 
8
the following: 
9
03:53 May 13, 2020
H6701
2 
•HR 6701 IH
‘‘SEC. 404O. STUDY ON THE IMPACT OF COVID–19. 
1
‘‘(a) IN GENERAL.—The Director of NIH, in con-
2
sultation with the Director of the Centers for Disease Con-
3
trol and Prevention, shall conduct a longitudinal study, 
4
over not less than 10 years, on the full impact of COVID– 
5
19 on infected individuals, including both short-term and 
6
long-term health impacts. 
7
‘‘(b) TIMING.—The Director of NIH shall begin en-
8
rolling patients in the study under this section not later 
9
than 6 months after the date of enactment of this section. 
10
‘‘(c) REQUIREMENTS.—The study under this section 
11
shall— 
12
‘‘(1) be nationwide; 
13
‘‘(2) include diversity of enrollees to account for 
14
gender, age, race, ethnicity, geography, comorbidi-
15
ties, and underrepresented populations, including 
16
pregnant and lactating women; 
17
‘‘(3) study individuals who were infected with 
18
COVID–19 who experienced mild symptoms, such 
19
individuals who experienced moderate symptoms, 
20
and such individuals who experienced severe symp-
21
toms; 
22
‘‘(4) monitor the health outcomes and symp-
23
toms of individuals who were infected with COVID– 
24
19, or had prenatal exposure to COVID–19, includ-
25
ing lung capacity and function, and immune re-
26
03:53 May 13, 2020
H6701
3 
•HR 6701 IH
sponse, taking into account any pharmaceutical 
1
interventions such individuals may have received; 
2
‘‘(5) monitor the mental health outcomes of in-
3
dividuals infected with COVID–19, taking into ac-
4
count any interventions that affected mental health; 
5
and 
6
‘‘(6) monitor individuals enrolled in the study 
7
not less frequently that twice per year after the first 
8
year of the individual’s infection with COVID–19. 
9
‘‘(d) PUBLIC-PRIVATE RESEARCH NETWORK.—For 
10
purposes of carrying out the study under this section, the 
11
Director of NIH may develop a network of public-private 
12
research partners, provided that all research, including the 
13
research carried out through any such partner, is available 
14
publicly. 
15
‘‘(e) SUMMARIES
OF FINDINGS.—The Director of 
16
NIH shall make public a summary of findings under this 
17
section not less frequently than once every 3 months for 
18
the first 2 years of the study, and not less frequently than 
19
every 6 months thereafter. Such summaries may include 
20
information about how the findings of the study under this 
21
section compare with findings from research conducted 
22
abroad. 
23
03:53 May 13, 2020
H6701
4 
•HR 6701 IH
‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—There 
1
are authorized to be appropriated such sums as may be 
2
necessary to carry out this section.’’. 
3
Æ 
03:53 May 13, 2020
H6701
